Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 25.9B | 24.4B | 22.3B | 21.1B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 84.2M | 1.0B | 812.7M | 507.5M |
Other operating expenses | 528.2M | 89.7M | 88.3M | 102.1M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 0 | 0 | 0 | 0 |
Pretax income | 1.2B | 1.2B | 894.7M | 1.0B |
Tax provision | 0 | 0 | 0 | 0 |
Net income | 1.2B | 1.2B | 894.7M | 1.0B |
Basic EPS | — | 1.3 | 1.0 | 1.1 |
Diluted EPS | — | 1.3 | 1.0 | 1.1 |
Basic average shares | — | 918.8M | 922.4M | 917.2M |
Diluted average shares | — | 925.9M | 932.0M | 917.2M |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |